|
1,2,3,4-tetrahydronaphthalene-1-hydroperoxide
|
C114452 |
|
|
4-hydroxybenzoyldehydrotumulosic acid
|
C114453 |
|
|
Minichromosome Maintenance Complex Component 3
|
D064126 |
[A minichromosome maintenance protein that is a key component of the six member MCM protein complex. It contains a NUCLEAR LOCALIZATION SIGNAL, which provide targeting of the protein complex. In addition, acetylation of this protein may play a role in regulating of DNA replication and cell cycle progression.
] |
|
ZEN-4 protein, C elegans
|
C114455 |
|
|
Aurora Kinases
|
D064127 |
[A family of highly conserved serine-threonine kinases that are involved in the regulation of MITOSIS. They are involved in many aspects of cell division, including centrosome duplication, SPINDLE APPARATUS formation, chromosome alignment, attachment to the spindle, checkpoint activation, and CYTOKINESIS.
] |
|
PPID protein, human
|
C114456 |
|
|
Nodding Syndrome
|
D064128 |
[Unexplained neurologic condition characterized by episodes of atonic seizures, convulsions or staring spells with further cognitive decline.
] |
|
SpaA protein, Erysipelothrix rhusiopathiae
|
C114457 |
|
|
Prostatic Neoplasms, Castration-Resistant
|
D064129 |
[Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.
] |
|
defensin protein, Formica rufa
|
C114458 |
|
|
4-phenyl-2-propionamidotetraline
|
C114459 |
|
|
cementum-derived growth factor, 14-kDa
|
C114460 |
|
|
DLG5 protein, human
|
C114461 |
|
|
multidrug resistance-associated protein 3
|
C114462 |
|
|
Premenstrual Dysphoric Disorder
|
D065446 |
[A condition in which a woman suffers from severe depression, irritability, and tension before MENSTRUATION. Premenstrual dysphoric disorder (PMDD) may involve a wide range of physical or emotional symptoms, which are more severe and debilitating than those seen with premenstrual syndrome (PMS), and which include at least one mood-related symptom. Symptoms usually stop when, or shortly after, menstruation begins.
] |
|
Practice Management, Veterinary
|
D065447 |
[The organization and operation of the business aspects of a veterinary practice.
] |
|
Cytoreduction Surgical Procedures
|
D065426 |
[Operative procedures carried out to reduce a mass of tissue, for example, to reduce the total amount of tissue composing a tumor.
] |
|
Factor Xa Inhibitors
|
D065427 |
[Endogenous factors and drugs that inhibit or block the activity of FACTOR XA.
] |
|
1-hydroxy-2-dodecyl-4(1H)quinolone
|
C521526 |
|
|
ceragenin CSA-8
|
C521527 |
|
